E. Weiland

2.3k total citations
66 papers, 1.9k citations indexed

About

E. Weiland is a scholar working on Genetics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, E. Weiland has authored 66 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 17 papers in Infectious Diseases and 16 papers in Molecular Biology. Recurrent topics in E. Weiland's work include Virus-based gene therapy research (20 papers), Animal Virus Infections Studies (16 papers) and Animal Disease Management and Epidemiology (15 papers). E. Weiland is often cited by papers focused on Virus-based gene therapy research (20 papers), Animal Virus Infections Studies (16 papers) and Animal Disease Management and Epidemiology (15 papers). E. Weiland collaborates with scholars based in Germany, United States and Croatia. E. Weiland's co-authors include R Stark, F. Weiland, Heinz‐Jürgen Thiel, Gregor Meyers, Till Rümenapf, H. Thiel, R. Ahl, B. Haas, M. Mussgay and Sebastian P. Maurer and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

E. Weiland

62 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Weiland Germany 22 968 735 664 580 470 66 1.9k
R. C. Wardley United Kingdom 30 985 1.0× 368 0.5× 721 1.1× 416 0.7× 253 0.5× 75 2.0k
L Coggins United States 21 943 1.0× 402 0.5× 401 0.6× 190 0.3× 374 0.8× 58 1.5k
J. H. Gillespie United States 22 527 0.5× 543 0.7× 645 1.0× 173 0.3× 506 1.1× 63 1.8k
Carmen M. Ruiz-Jarabo Spain 19 815 0.8× 206 0.3× 547 0.8× 778 1.3× 426 0.9× 20 2.0k
Norbert Tautz Germany 28 1.8k 1.9× 589 0.8× 842 1.3× 996 1.7× 243 0.5× 52 2.6k
Llilianne Ganges Spain 28 1.3k 1.3× 670 0.9× 589 0.9× 919 1.6× 229 0.5× 84 1.9k
Rongliang Hu China 27 941 1.0× 258 0.4× 759 1.1× 473 0.8× 327 0.7× 105 2.2k
Yoshio Fukunaga Japan 18 446 0.5× 472 0.6× 551 0.8× 237 0.4× 233 0.5× 72 1.2k
William H. McCollum United States 26 513 0.5× 1.8k 2.4× 836 1.3× 1.1k 1.9× 649 1.4× 56 2.0k
O.‐R. Kaaden Germany 20 434 0.4× 217 0.3× 431 0.6× 241 0.4× 247 0.5× 80 1.3k

Countries citing papers authored by E. Weiland

Since Specialization
Citations

This map shows the geographic impact of E. Weiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Weiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Weiland more than expected).

Fields of papers citing papers by E. Weiland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Weiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Weiland. The network helps show where E. Weiland may publish in the future.

Co-authorship network of co-authors of E. Weiland

This figure shows the co-authorship network connecting the top 25 collaborators of E. Weiland. A scholar is included among the top collaborators of E. Weiland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Weiland. E. Weiland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Beyer, J., Dieter Fichtner, Horst Schirrmeier, et al.. (1998). Arterivirus PRRSV. Experimental studies on the pathogenesis of respiratory disease.. PubMed. 440. 593–9. 7 indexed citations
4.
Pauly, Thomas H., E. Weiland, Werner Hirt, et al.. (1996). Differentiation between MHC‐restricted and non‐MHC‐restricted porcine cytolytic T lymphocytes. Immunology. 88(2). 238–246. 55 indexed citations
5.
Ahl, R., et al.. (1995). Differentiation of classical swine fever virus (CSFV) strains using monoclonal antibodies against structural glycoproteins. Veterinary Microbiology. 47(1-2). 111–118. 39 indexed citations
6.
Ahl, R., et al.. (1994). Die Schweinepest in Deutschland in den Jahren 1992 und 1993. 25–28. 1 indexed citations
7.
Saalmüller, Armin, Bent Aasted, A. Canals, et al.. (1994). Analyses of monoclonal antibodies reactive with porcine CD6. Veterinary Immunology and Immunopathology. 43(1-3). 243–247. 23 indexed citations
8.
Saalmüller, Armin, Werner Hirt, Sebastian P. Maurer, & E. Weiland. (1994). Discrimination between two subsets of porcine CD8+ cytolytic T lymphocytes by the expression of CD5 antigen.. PubMed. 81(4). 578–83. 75 indexed citations
9.
Saalmüller, Armin, Bent Aasted, A. Canals, et al.. (1994). Summary of workshop findings for porcine T-lymphocyte antigens. Veterinary Immunology and Immunopathology. 43(1-3). 219–228. 24 indexed citations
10.
Pescovitz, M.D., Bent Aasted, A. Canals, et al.. (1994). Analysis of monoclonal antibodies reactive with the porcine CD4 antigen. Veterinary Immunology and Immunopathology. 43(1-3). 233–236. 21 indexed citations
11.
Straub, O. C., et al.. (1993). Untersuchungen über den Verlauf einer Infektion mit Border-Disease-Virus in einer Schafherde und ein Vorschlag zur Bekämpfung der Krankheit. Tierärztliche Umschau. 48(7). 442–446. 1 indexed citations
12.
Weiland, E., R. Ahl, R Stark, F. Weiland, & Heinz‐Jürgen Thiel. (1992). A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus. Journal of Virology. 66(6). 3677–3682. 144 indexed citations
13.
Ohlinger, Volker, F. Weiland, Bernd Haas, et al.. (1991). Der "Seuchenhafte Spätabort beim Schwein" - ein Beitrag zur Ätiologie des "Porcinen Reproductive and Respiratory Syndrome (PRRS)". OpenAgrar. 5 indexed citations
14.
Weiland, E., Angelika Grossmann, Heinz‐Jürgen Thiel, & F. Weiland. (1990). Lactate Dehydrogenase-elevating Virus Induces Antibodies Reactive with a Surface Antigen of Aetiologically Unrelated Murine Cell Transformants. Journal of General Virology. 71(5). 1233–1236. 5 indexed citations
15.
Weiland, E. & F. Weiland. (1985). Detection and preliminary characterization of a transmissible agent inducing autoantibody against Golgi-antigen.. PubMed Central. 62(1). 167–75. 5 indexed citations
16.
Weiland, E., M. Mussgay, & F. Weiland. (1978). Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.. The Journal of Experimental Medicine. 148(2). 408–423. 27 indexed citations
17.
Weiland, E. & M. Mussgay. (1977). Presence of splenic suppressor cells in mice bearing regressively growing Moloney sarcomas and their absence in progressor mice. European Journal of Cancer (1965). 13(7). 705–711. 3 indexed citations
18.
Weiland, E. & F. Weiland. (1974). [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].. PubMed. 148(2). 151–61. 3 indexed citations
20.
Weiland, E., et al.. (1970). Untersuchcungen zum Verhalten von Cryptococcus Neoformans in Erde: 1. Mitteilung: Vorkommen in Erde, Überlebensfähigkeit in Seesand, Leistungsvergleich unterschiedlicher Nachweismethoden. 42. 57–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026